06855 亞盛醫藥-B
公司資料 - 財務狀況表
亞盛醫藥集團 股票編號: 06855
ASCENTAGE PHARMA GROUP INTERNATIONAL 集團網址: http://www.ascentagepharma.com
非流動資產
2025/06 - 中期
人民幣(¥)
與去年末期
比較
2024/12
人民幣(¥)
2023/12
人民幣(¥)
2022/12
人民幣(¥)
2021/12
人民幣(¥)
投資物業0--00355,425,0000
物業、廠房、設備及其他821,201,000-3.326%849,450,000905,815,000602,086,000797,029,000
租賃土地50,760,000-9.533%56,109,00051,252,00046,636,00047,339,000
無形資產95,688,000-4.970%100,692,000110,140,000108,998,00085,105,000
聯營公司及共同控制公司權益32,718,0000.003%32,717,00016,998,00015,922,00016,200,000
其他非流動資產137,057,00030.929%104,680,00072,010,00064,706,000109,107,000
1,137,424,000-0.544%1,143,648,0001,156,215,0001,193,773,0001,054,780,000
存貨8,591,00030.226%6,597,00016,167,0009,448,0003,930,000
 
流動資產
現金及銀行結存1,661,454,00031.735%1,261,211,0001,093,833,0001,492,240,0001,743,821,000
其他流動資產238,675,00015.663%206,354,000234,178,000134,800,000137,529,000
持作出售資產0--0000
1,908,720,00029.478%1,474,162,0001,344,178,0001,636,488,0001,885,280,000
 
流動負債
其他流動負債1,239,302,0006.231%1,166,611,000934,173,000881,152,000361,109,000
持作出售資產相關負債0--0000
1,239,302,0006.231%1,166,611,000934,173,000881,152,000361,109,000
流動資產淨值669,418,000117.661%307,551,000410,005,000755,336,0001,524,171,000
資產總額減流動負債1,806,842,00024.507%1,451,199,0001,566,220,0001,949,109,0002,578,951,000
 
非流動負債
1,130,933,000-3.917%1,177,037,0001,495,588,0001,540,451,0001,344,214,000
 
資本及儲備
   股本239,00011.682%214,000197,000180,000178,000
   儲備665,758,000152.200%263,980,00060,220,000408,478,0001,234,559,000
   其他0--0000
股東資金665,997,000152.086%264,194,00060,417,000408,658,0001,234,737,000
非控股權益9,912,000-0.562%9,968,00010,215,00000
其他0--0000
675,909,000146.536%274,162,00070,632,000408,658,0001,234,737,000
 
承擔及或然負債
承擔----4,366,0002,534,0002,269,000160,725,000
或然負債----0000
 

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.